OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Modern Retina. All rights reserved.
New York-Members of the FDA's advisory committee reviewing pegaptanib sodium injection (Macugen) for the treatment of neovascular age-related macular degeneration say they are "impressed" with the drug but declined to take a formal vote.